日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy.

CRISPR-Cas9 筛选可识别肝癌中由 ATOX1 驱动的顺铂耐药机制，并评估靶向抑制剂的疗效。

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-026-09722-8
Hu Chujiao, Tai Huading, Zhu Renguang, Shu Zhengyu, Guo Guanghao, Ma Dan, Zuo Shi, Tang Lei, Zeng Zhirui
肝癌
肿瘤
TOX
CAS9
ATOX1
发表日期：2026
文献求助 收藏

Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting.

全基因 CRISPR/Cas9 文库筛选显示，靶向 STAT6 可通过抑制花生四烯酸分流来提高肝癌对塞来昔布的敏感性

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-025-02374-x
Hu Chujiao, Zeng Zhirui, Bao Xin, Li Dahuan, Tai Huading, Zeng Haohao, Luo Cheng, Tang Lei, Chen Tengxiang, Zuo Shi
肿瘤
肝癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Breast Cancer Prediction Based on Multiple Machine Learning Algorithms

基于多种机器学习算法的乳腺癌预测

期刊:Technology in Cancer Research & Treatment
影响因子:2.8
doi:10.1177/15330338241234791
Zhou, Sheng; Hu, Chujiao; Wei, Shanshan; Yan, Xiaofan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma

对PPARG作为致癌驱动因子的综合研究和实验验证：对肝细胞癌预后评估和治疗靶向的意义

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1298341
Ran, Yunsheng; Hu, Chujiao; Wan, Junzhao; Kang, Qian; Zhou, Ruixian; Liu, Ping; Ma, Dan; Wang, Jianta; Tang, Lei
肿瘤
肿瘤免疫
PARG
细胞生物学
PPARG
发表日期：2023
文献求助 收藏